Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumors

Prog Clin Biol Res. 1989:303:739-47.
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cisplatin / administration & dosage
  • Drug Evaluation
  • Etoposide / administration & dosage
  • Humans
  • Ifosfamide / administration & dosage
  • Male
  • Neoplasms, Germ Cell and Embryonal / drug therapy*
  • Testicular Neoplasms / drug therapy*

Substances

  • Etoposide
  • Cisplatin
  • Ifosfamide